Free Trial

Spire Healthcare Group (LON:SPI) Announces Quarterly Earnings Results

Spire Healthcare Group logo with Medical background

Key Points

  • Spire Healthcare Group reported earnings of GBX 4.10 ($0.05) per share for the quarter, with a net margin of 1.96% and return on equity of 3.82%.
  • Following the earnings announcement, shares declined by 2.1%, trading at GBX 213.50 ($2.82) on Friday.
  • Berenberg Bank has set a new price target of GBX 280 ($3.70) on the stock, maintaining a "buy" rating.
  • Five stocks to consider instead of Spire Healthcare Group.

Spire Healthcare Group (LON:SPI - Get Free Report) announced its quarterly earnings data on Thursday. The company reported GBX 4.10 ($0.05) EPS for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%.

Spire Healthcare Group Stock Performance

LON SPI remained flat at GBX 207 ($2.75) during trading on Tuesday. The company's stock had a trading volume of 567,628 shares, compared to its average volume of 1,346,833. The firm has a market capitalization of £831.25 million, a P/E ratio of 29.46, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The stock has a fifty day moving average price of GBX 215.68 and a 200 day moving average price of GBX 206.22. Spire Healthcare Group has a 12 month low of GBX 168.20 ($2.24) and a 12 month high of GBX 260.50 ($3.46). The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70.

Analysts Set New Price Targets

Several equities analysts have commented on the company. JPMorgan Chase & Co. cut their price target on Spire Healthcare Group from GBX 309 ($4.11) to GBX 303 ($4.03) and set an "overweight" rating for the company in a report on Tuesday. Berenberg Bank restated a "buy" rating and issued a GBX 280 ($3.72) target price on shares of Spire Healthcare Group in a research note on Thursday, July 31st.

Get Our Latest Stock Analysis on Spire Healthcare Group

About Spire Healthcare Group

(Get Free Report)

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

See Also

Should You Invest $1,000 in Spire Healthcare Group Right Now?

Before you consider Spire Healthcare Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.

While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines